Daré Bioscience Furnishes Updated Corporate Presentation via 8-K
Dare Bioscience, Inc.
Subscribe to track DARE
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Daré Bioscience Furnishes Updated Corporate Presentation via 8-K
Company: Daré Bioscience, Inc. (DARE)
Form: 8-K | Filed: 2026/10/01
Significance: Low
Filing Summary: • Item 7.01: Regulation FD Disclosure • Exhibit 99.1: Corporate Presentation dated October 1, 2026 • Authorized Signatory: Sabrina Martucci Johnson (President & CEO)
Key Insight: Daré Bioscience furnished an updated corporate presentation intended for use in upcoming meetings with securities market participants and investors. No material financial restructuring or insider equity transactions occurred.
Comprehensive Analysis
SEC Filing Analysis: Daré Bioscience, Inc. (DARE)
Executive Summary
- Trading Significance: Low
- Key Takeaway: Daré Bioscience furnished an updated corporate presentation under Item 7.01 (Regulation FD Disclosure) for upcoming investor meetings.
- Market Impact: Neutral; routine corporate communication with no direct dilution or capital structure modification.
Company Information
| Field | Value |
|---|---|
| Company | Daré Bioscience, Inc. |
| Ticker Symbol | DARE |
| CIK | 0001401914 |
| Industry | Pharmaceutical Preparations [2834] |
Filing Overview
| Field | Value |
|---|---|
| Form Type | 8-K |
| Items Reported | Item 7.01 (Regulation FD), Item 9.01 (Exhibits) |
| Filing Date | 2026/10/01 |
| Accession Number | 0001493152-26-045275 |
| Exhibit Furnished | Exhibit 99.1 (Corporate Presentation) |
Financial & Materiality Context
- Market Capitalization: ~$20.0M (Micro-cap)
- Shares Outstanding: 14,980,000 shares
- Transaction Impact: Not applicable; this filing contains no equity issuance, share repurchase, or insider trade.
- Dilution Impact: None from this disclosure.
Market Impact Analysis
- Direction: Neutral
- Reasoning: Item 7.01 filings are furnished rather than filed under Section 18 of the Securities Exchange Act and typically represent routine corporate slide deck updates for roadshows and conferences.
- Sentiment: Neutral
Additional Context
- Presentation Availability: The company stated that the presentation will be posted to the Investor Relations section of its website.
- Signatory: Sabrina Martucci Johnson, President and Chief Executive Officer.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.